Omnes, in collaboration with Regenerus Labs, has undergone a significant merger that brings together a prominent test supplier with a cutting-edge digital platform for practitioners. This merger is set to revolutionize the industry by providing practitioners with efficient tools to manage and analyze client health data. The Omnes platform stands out as one of the most advanced in the market, offering health professionals and their clients the ability to cross-reference personalized questionnaire data with advanced functional diagnostic tests.

By doing so, the platform recommends the most suitable tests or test packages for an individual's symptoms. These tests can be conveniently purchased online or through a health practitioner, and blood tests are easily accessible through a network of over 140 phlebotomists across the UK. Once test results are uploaded, the platform employs unique algorithms to analyze an individual's health, rendering clear explanations and recommendations.

Exciting developments are underway to enhance access and interaction with testing and wider health data, including the ability for practitioners to upload historical data onto the platform. The combined company, with 28 employees and offices in Edinburgh and Redhill, is projected to generate approximately £5 million in revenue for 2023. With this merger, Omnes and Regenerus Labs are poised to offer a scientifically robust and powerful range of tests and tools to support health practitioners and improve client outcomes